highperformr logo

Kite Pharma's Overview

Total employees3983
HeadquartersSanta Monica
Founded2009

Kite, a Gilead Company, is a biopharmaceutical company at the forefront of developing and commercializing innovative cancer immunotherapy products. Their focus is on engineered T cell therapies, such as CAR T-cell therapy, designed to harness the power of a patient's own immune system to target and kill cancer cells. Kite is dedicated to advancing science and delivering potentially curative therapies to patients with hematologic cancers and solid tumors.

Where is Kite Pharma's Headquarters?

HQ Function

Serves as the central hub for Kite's global operations, including research and development leadership, corporate strategy, and administrative functions for its pioneering work in cell therapy.

Notable Features:

State-of-the-art facilities designed to support cutting-edge research and development in cell therapy, including advanced laboratories and collaborative workspaces. Proximity to other biotech companies and research institutions.

Work Culture:

A fast-paced, innovative, and patient-focused environment driven by a mission to cure cancer. Emphasis on collaboration, scientific excellence, and a sense of urgency in bringing transformative therapies to patients.

HQ Significance:

The Santa Monica headquarters is central to Kite's identity as a leader in CAR T-cell therapy, housing key decision-makers and research teams driving the company's scientific advancements.

Values Reflected in HQ: The headquarters embodies Kite's commitment to innovation, scientific rigor, and patient-centricity, with spaces designed to foster collaboration and accelerate the development of life-saving therapies.

Location:

Kite, as a Gilead company, supports global functions including research and development, clinical trials, manufacturing, and commercialization of its cell therapies. Key operational hubs are in North America (USA) and Europe (Netherlands), with a growing reach to make its therapies available to patients worldwide through Gilead's established international infrastructure.

Street Address:

2400 Broadway

City:

Santa Monica

State/Province:

California

Country:

USA

Kite Pharma's Global Presence

Frederick, Maryland, USA

Address: 9021 Bennett Creek Blvd, Frederick, MD 21704, USA

Serves as a key node in Kite's manufacturing network, enabling the production and supply of cell therapies to patients in North America. Supports the company's commitment to reliable and timely delivery of these life-saving treatments.

Hoofddorp, Netherlands

Address: Taurusavenue 107, 2132 LS Hoofddorp, Netherlands

Ensures the supply of Kite's innovative cell therapies to patients across Europe and supports the company's growing presence and market access in the region. It's a strategic hub for European clinical development and commercial activities.

Buying Intent Signals for Kite Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Kite Pharma

As of April 2025, Kite Pharma' leadership includes:

Cindy Perettie - Executive Vice President, Gilead Sciences and Head of Kite
Frank Neumann, M.D., Ph.D. - SVP, Global Head of Clinical Development, Kite
Chris Picking - SVP, Global Head of Commercial, Kite
Charles Calderaro - SVP, Global Head of Technical Operations, Kite
Dick Sundh - SVP, Global Head of Quality, Kite

Investors of Kite Pharma

Kite Pharma has been backed by several prominent investors over the years, including:

Gilead Sciences, Inc. (Parent Company)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

Kite has seen strategic leadership appointments and transitions over the last 12 months to further strengthen its capabilities in cell therapy development and commercialization. Key movements focus on enhancing research, clinical development, and overall leadership.

Departures

Christi Shaw, Christi Shaw transitioned from her role as CEO of Kite following the appointment of Cindy Perettie as Head of Kite.
Francesco Marincola, M.D., Dr. Francesco Marincola departed from his role leading cell therapy research at Kite.

New Appointments:

Cindy Perettie, Cindy Perettie appointed to lead Kite, bringing extensive oncology and cell therapy leadership experience.
Ken Geles, Ken Geles joined Kite to lead global medical affairs, strengthening its scientific and medical engagement.

Technology (Tech Stack) used by Kite Pharma

Discover the tools Kite Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Kite Pharma Email Formats and Examples

As Kite is a Gilead company, email formats generally follow Gilead Sciences' corporate conventions. The most common format observed is [firstname].[lastname]@gilead.com. While variations might exist, this pattern is standard for corporate communications.

[first].[last]@gilead.com

Format

jane.doe@gilead.com

Example

85%

Success rate

News and media

Fierce PharmaMay 8, 2024

Kite Pharma, Inc. news: Gilead's Kite braces for Yescarta manufacturing crunch ahead of key BCMA CAR-T launch

Kite is experiencing high demand for its CAR T-cell therapy Yescarta, leading to manufacturing capacity challenges as it prepares for a potential new BCMA-targeted CAR-T therapy launch and aims to expand access....more

Gilead Sciences Press RoomApril 29, 2024

Kite Pharma, Inc. news: Yescarta® CAR T-cell Therapy Shows Clinically Meaningful Improvement in Overall Survival in Second-Line Relapsed or Refractory Large B-cell Lymphoma

Results from the Phase 3 ZUMA-7 study showed that Kite's Yescarta (axicabtagene ciloleucel) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to standard of care for adult patients with relapsed or refractory large B-cell lymphoma (LBCL) after first-line chemoimmunotherapy....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Kite Pharma, are just a search away.